← Back to Clinical Trials
Recruiting NCT05726331

NCT05726331 Chronic Non-Specific Neck Pain Treated With Tai Chi and Chiropractic Care

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05726331
Status Recruiting
Phase
Sponsor Harvard University Faculty of Medicine
Condition Neck Pain
Study Type INTERVENTIONAL
Enrollment 48 participants
Start Date 2023-10-25
Primary Completion 2026-04-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Chiropractic CareTai ChiEnhanced Usual Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 48 participants in total. It began in 2023-10-25 with a primary completion date of 2026-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This feasibility project aims to evaluate the effectiveness of chiropractic care combined with Tai Chi (TC) training to reduce pain and disability in adults with chronic non-specific neck pain (CNNP).

Eligibility Criteria

Inclusion Criteria: * Chronic nonspecific neck pain at least 5 days a week for at least 3 consecutive months * Neck pain averaged over past week of 3 or more on numerical rating scale ranging from 0 to 10, with 10 described as 'worst neck pain imaginable' * Neck Disability Index score of 5 or greater * Agreeable to participate in all study procedures and be randomized to all intervention groups * Fluent in English Exclusion Criteria: * Currently, or having received chiropractic care in past 12 months * Regular practice (on average, weekly) of Yoga, Tai Chi or Qigong in the past 6 months * Any major systemic illness or unstable medical condition (e.g. Parkinson's disease, cancer) or psychiatric condition requiring immediate treatment or that could lead to difficulty complying with the protocol * Any disability precluding exercise practice * History of stroke, carotid artery dissection, or vertebral artery dissection * Signs of myelopathy or carotid bruits or evidence of pathological hypermobility (e.g. Ehlers Danlos Syndrome) during the clinical exam * Neck pain caused by congenital deformity of the spine that contraindicate treatment, neck pain related to neoplasm, inflammatory rheumatic disease, neurological disorder, active oncologic disease, severe affective disorder, addiction, or psychosis * Neck pain associated with unstable radicular pain or radiculopathy * Pregnancy * Recent spinal injections (in the past 4 weeks) * Neck pain with litigation * Any prior cervical surgery/spinal surgery within previous year * Persons currently involved in a disability/accident claim

Contact & Investigator

Central Contact

Jacqui Guzman, BA

✉ jguzman5@bwh.harvard.edu

📞 617-732-9418

Frequently Asked Questions

Who can join the NCT05726331 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Neck Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05726331 currently recruiting?

Yes, NCT05726331 is actively recruiting participants. Contact the research team at jguzman5@bwh.harvard.edu for enrollment information.

Where is the NCT05726331 trial being conducted?

This trial is being conducted at Chestnut Hill, United States.

Who is sponsoring the NCT05726331 clinical trial?

NCT05726331 is sponsored by Harvard University Faculty of Medicine. The trial plans to enroll 48 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology